↓ Skip to main content

Phosphodiesterases as Drug Targets

Overview of attention for book
Cover of 'Phosphodiesterases as Drug Targets'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Phosphodiesterase Inhibitors: History of Pharmacology
  3. Altmetric Badge
    Chapter 2 Phosphodiesterase Inhibitors: Factors That Influence Potency, Selectivity, and Action
  4. Altmetric Badge
    Chapter 3 Pharmacology, clinical efficacy, and tolerability of phosphodiesterase-4 inhibitors: impact of human pharmacokinetics.
  5. Altmetric Badge
    Chapter 4 Structural Insight into the Substrate Specificity of Phosphodiesterases
  6. Altmetric Badge
    Chapter 5 A Fission Yeast-Based Platform for Phosphodiesterase Inhibitor HTSs and Analyses of Phosphodiesterase Activity
  7. Altmetric Badge
    Chapter 6 The GAF-Tandem Domain of Phosphodiesterase 5 as a Potential Drug Target
  8. Altmetric Badge
    Chapter 7 Small Molecule Allosteric Modulators of Phosphodiesterase 4
  9. Altmetric Badge
    Chapter 8 Regulation of Endothelial Barrier Function by Cyclic Nucleotides: The Role of Phosphodiesterases
  10. Altmetric Badge
    Chapter 9 Phosphodiesterases as Targets for Intermittent Claudication
  11. Altmetric Badge
    Chapter 10 Phosphodiesterase Inhibition in Heart Failure
  12. Altmetric Badge
    Chapter 11 Phosphodiesterases: Emerging Therapeutic Targets for Neonatal Pulmonary Hypertension
  13. Altmetric Badge
    Chapter 12 Role of Phosphodiesterases in Adult-Onset Pulmonary Arterial Hypertension
  14. Altmetric Badge
    Chapter 13 Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms by Phosphodiesterase Inhibitors
  15. Altmetric Badge
    Chapter 14 Evaluation of the Therapeutic Utility of Phosphodiesterase 5A Inhibition in the mdx Mouse Model of Duchenne Muscular Dystrophy
  16. Altmetric Badge
    Chapter 15 Phosphodiesterases as Targets for Modulating T-Cell Responses
  17. Altmetric Badge
    Chapter 16 Cyclic Nucleotides and Phosphodiesterases in Monocytic Differentiation
  18. Altmetric Badge
    Chapter 17 Phosphodiesterase Inhibitors in the Treatment of Inflammatory Diseases
  19. Altmetric Badge
    Chapter 18 Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination Therapies
  20. Altmetric Badge
    Chapter 19 Phosphodiesterases in the Central Nervous System: Implications in Mood and Cognitive Disorders
  21. Altmetric Badge
    Chapter 20 Therapeutic Potential of Phosphodiesterase Inhibitors in Parasitic Diseases
Overall attention for this book and its chapters
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
1 X user
wikipedia
4 Wikipedia pages

Readers on

mendeley
161 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phosphodiesterases as Drug Targets
Published by
Handbook of experimental pharmacology, January 2011
DOI 10.1007/978-3-642-17969-3
ISBNs
978-3-64-217968-6, 978-3-64-217969-3
Authors

Sharron H. Francis, Marco Conti, Miles D. Houslay

Editors

Francis, Sharron H., Conti, Marco, Houslay, Miles D.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 6 4%
Netherlands 1 <1%
Austria 1 <1%
Germany 1 <1%
United Kingdom 1 <1%
Brazil 1 <1%
Spain 1 <1%
Singapore 1 <1%
Unknown 148 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 31 19%
Researcher 31 19%
Student > Master 25 16%
Student > Bachelor 19 12%
Student > Postgraduate 10 6%
Other 30 19%
Unknown 15 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 47 29%
Medicine and Dentistry 33 20%
Pharmacology, Toxicology and Pharmaceutical Science 21 13%
Biochemistry, Genetics and Molecular Biology 13 8%
Chemistry 13 8%
Other 13 8%
Unknown 21 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#6,954,391
of 22,805,349 outputs
Outputs from Handbook of experimental pharmacology
#204
of 648 outputs
Outputs of similar age
#50,903
of 180,739 outputs
Outputs of similar age from Handbook of experimental pharmacology
#7
of 22 outputs
Altmetric has tracked 22,805,349 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 648 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,739 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.